Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/03/16 → 1/03/16 |
Funding
- National Health and Medical Research Council (NHMRC) (Australia): A$616,992.00
EphA3, a novel target for leukaemia stem-cell therapy
- Slape, Christopher (Primary Chief Investigator (PCI))
- Boyd, Andrew Wallace (Chief Investigator (CI))
Project: Research